Xtl Biopharmaceuticals (XTLB) Profit After Tax (2009 - 2024)
Xtl Biopharmaceuticals' Profit After Tax was -$759,000 in the year ended Dec 31, 2025, compared with $110,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Profit After Tax (2009 - 2024) Analysis & Trends
From the year ended Dec 31, 2009 onward, Xtl Biopharmaceuticals has reported Profit After Tax for 17 years.
- Annual Profit After Tax has moved between -$1.78 million (the year ended Dec 31, 2023) and $110,000 (the year ended Dec 31, 2024) over five years.
- Per Business Quant data, Profit After Tax in earlier years was $110,000 in the year ended Dec 31, 2024, -$1.78 million in the year ended Dec 31, 2023, -$1.35 million in the year ended Dec 31, 2022 and -$1.03 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 585,000.00 |
| Sep 30, 2024 | -764,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -151,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -225,000.00 |
| Sep 30, 2022 | -204,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | -210,000.00 |
| Jun 30, 2021 | -303,000.00 |
| Mar 31, 2021 | -232,000.00 |
| Dec 31, 2020 | -257,000.00 |
| Sep 30, 2020 | -217,000.00 |
| Jun 30, 2020 | -217,000.00 |
| Mar 31, 2020 | -257,000.00 |
API Access
Xtl Biopharmaceuticals Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();